Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm

by Pierre-Eric Juif, Jasper Dingemanse, Mike Ufer
Published 2021-02-01

Cardiodynamic Interactions between Two S1P₁ Receptor Modulators in an Experimental Clinical Setting: Different Pharmacokinetic Properties as an Opportunity to Mitigate F...

by Pierre-Eric Juif, Mike Ufer, Jasper Dingemanse
Published 2019-07-01

Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P1R Modulator, Are Not Affected by Ethnicity in Healthy Asian and White Subjects

by Pierre‐Eric Juif, Jasper Dingemanse, Peter Winkle, Mike Ufer
Published 2021-01-01

Influence of Rifampin‐Mediated Organic Anion‐Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan

by Pierre‐Eric Juif, Christine Voors‐Pette, Mike Ufer, Peter Dogterom, Jasper Dingemanse
Published 2019-09-01

Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P1 Receptor Modulator in Healthy Subjects

by Pierre-Eric Juif, Daniela Baldoni, Maribel Reyes, Darren Wilbraham, Salvatore Febbraro, Andrea Vaclavkova, Matthias Hoch, Jasper Dingemanse
Published 2017-12-01